Clal Biotechnology Industries Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Avi Fischer
Chief executive officer
₪586.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 2.5yrs |
| Board average tenure | 7.1yrs |
Recent management updates
Recent updates
Clal Biotechnology Industries (TLV:CBI) Is Carrying A Fair Bit Of Debt
Oct 09
The Market Doesn't Like What It Sees From Clal Biotechnology Industries Ltd.'s (TLV:CBI) Revenues Yet
Apr 18Calculating The Fair Value Of Clal Biotechnology Industries Ltd. (TLV:CBI)
Jul 14Does Clal Biotechnology Industries (TLV:CBI) Have A Healthy Balance Sheet?
Jan 19Investors Shouldn't Be Too Comfortable With Clal Biotechnology Industries' (TLV:CBI) Robust Earnings
Mar 25Clal Biotechnology Industries (TLV:CBI) Seems To Use Debt Quite Sensibly
Mar 24Introducing Clal Biotechnology Industries (TLV:CBI), The Stock That Zoomed 121% In The Last Year
Feb 16
What Kind Of Shareholders Own Clal Biotechnology Industries Ltd. (TLV:CBI)?
Jan 12Is Clal Biotechnology Industries (TLV:CBI) Using Too Much Debt?
Dec 07CEO
Avi Fischer (68 yo)
less than a year
Tenure
₪586,000
Compensation
Dr. Avraham Matityahu Fischer, also known as Avi, M.D., is Co-Managing Partner of Fischer Behar Chen Well Orion & Co. Dr. Fischer is Deputy CEO, Executive VP and Deputy Chairman of Idb Development Corporat...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | less than a year | ₪586.00k | no data | |
| Chief Financial Officer | 2.2yrs | ₪975.00k | no data | |
| Accountant | 2.9yrs | no data | no data | |
| General Counsel & Corporate Secretary | no data | no data | no data | |
| Vice President of Research & Development - MediWound | no data | ₪1.10m | no data | |
| Vice President of Medical Technologies - MediWound | no data | ₪1.21m | no data | |
| Medical Director | 2.9yrs | no data | no data |
2.5yrs
Average Tenure
61.5yo
Average Age
Experienced Management: CBI's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 21.6yrs | ₪586.00k | no data | |
| External Independent Director | 9yrs | no data | no data | |
| Director | less than a year | no data | no data | |
| Independent External Director | 4.8yrs | no data | no data | |
| Director | 21.8yrs | no data | no data | |
| Director | 7.1yrs | no data | no data | |
| Director | 7yrs | no data | no data |
7.1yrs
Average Tenure
68yo
Average Age
Experienced Board: CBI's board of directors are considered experienced (7.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 06:36 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Clal Biotechnology Industries Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pravin Gondhale | Virtua Research Inc. |